
|Videos|July 24, 2021
Surgical updates for Bausch + Lomb
Chuck Hess shares an update on Bausch + Lomb's latest developments in surgical technology, as well as how the company has adapted its operations during the pandemic.
Advertisement
Chuck Hess, vice president and general manager, U.S. Surgical (Bausch +Lomb), shares an update on Bausch + Lomb's latest developments in surgical technology — including ClearVisc™, a dispersive ophthalmic viscosurgical device — as well as how the company has adapted its operations during the pandemic.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy
2
FDA feedback supports Azura’s Ophthalmic's planned NDA for AZR-MD-001 in MGD
3
Alcon raises offer in amended deal to acquire STAAR Surgical
4
Neurotrophic keratitis outcomes improve with early, stage-based care
5













































.png)


